A brilliant post Boricka, businesslike and factual....thank you.
There should be no sides or conflicts in shareholders wishing and deserving competent management. There must be one goal, one focus, success.
Not one share sold, despite doubling for a few minutes this morning....
ActiPatch has helped and continues to help many here and potentially hundreds of millions globally.
A magical, breakthrough pain management device like ActiPatch cannot fail to deliver, but incompetent management and Founder's Syndrome can and have. Imploded deals with Bayer/Dr. Scholl's, KT Tape and CVS caused only by the CBO, CEO are facts.
Imagine what BIEL would be trading at this moment had Whelan retired to Chairman only with a non-interference committment and the competent management team and cash injection he and his daughter also said "No" to in April? Imagine a turned on BIEL team pounding the retail pavement making deals?
As said, if the CBO, CEO is not an inept, over the hill, bungler, the stock price should have risen just with speculation of real deals and sales, that's how markets react and discount great news early. If he is an inept, over the hill, bungler, then the price will stay in the toilet and he needs to retire, as he declared to several people he wished to in March.. Simple.
A stock running because of a regulatory clearance, which BIEL products have deserved for years, is not indicative of competent management. Imagine what the company and the share price could easily do, if both components were present.... pick a number, it would only be going up. A CBO, CEO retirement to Chair will be bigger than FDA clearance.
News 
Market Data 
Discover 
